Molecular and Cellular Biochemistry

, Volume 298, Issue 1–2, pp 179–186 | Cite as

Progesterone-dependent and -independent expression of the multidrug resistance type I gene in porcine granulosa cells

  • Hiroaki Fukuda
  • Pei Jian He
  • Kazuko Yokota
  • Tomoki Soh
  • Nobuhiko Yamauchi
  • Masa-aki Hattori
Original paper


A primary role of plasma membrane P-glycoprotein (P-gp), encoded by multidrug resistance type I (MDR1), is to protect against naturally occurring xenotoxics. Progesterone (P4) profoundly influences MDR1 expression in granulosa cells and luteal cells. Here, P4 regulation of MDR1 expression was investigated in porcine granulosa cells using the P4-mediated promoter activity assay and a P4 receptor (PR) antagonist (RU-486). The promoter activity was measured chronologically for 48 h in cells transfected with the PR response element-containing pGL3. LH could stimulate the promoter activity through endogenous P4, with a maximum activity at 5 h. MDR1 mRNA level was highly maintained at 24–36 h. Conversely, exogenous P4 prolonged the promoter activity to further 10 h, and the high level of MDR1 mRNA was maintained even at 48 h. RU-486 completely inhibited the promoter activity, but the level of MDR1 mRNA rapidly increased in the presence of RU-486. The granulosa cells may become susceptible to RU-486 as a xenotoxic to rapidly express MDR1 for protection against it. These results indicate that MDR1 is expressed in porcine granulosa cells through P4-dependent and -independent regulations.


MDR1 expression Progesterone RU-486 Granulosa cells Promoter activity 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.



This work was supported in part by a Grant-in-Aid for Scientific Research (B) No. 16380200 from the Japanese Ministry of Education, Culture, Sports, Science and Technology (to M-A H).


  1. 1.
    Hyde SC, Emsley P, Hartshorn MJ, Mimmack MM, Gileadi U, Pearce SR, Gallagher MP, Gill DR, Hubbard RE, Higgins CF (1990) Structural model of ATP-binding proteins associated with cystic fibrosis, multidrug resistance and bacterial transport. Nature 346:362–365PubMedCrossRefGoogle Scholar
  2. 2.
    Ueda K, Clark DP, Chen CJ, Roninson IB, Gottesman MM, Pastan I (1987) The human multidrug resistance (mdr1) gene. cDNA cloning and transcription initiation. J Biol Chem 262:505–508PubMedGoogle Scholar
  3. 3.
    Gottesman MM, Hrycyna CA, Schoenlein PV, Germann UA, Pastan I (1995) Genetic analysis of the multidrug transporter. Annu Rev Genet 29:607–649PubMedCrossRefGoogle Scholar
  4. 4.
    Gros P, Croop J, Housman D (1986) Mammalian multidrug resistance gene: complete cDNA sequence indicates strong homology to bacterial transport proteins. Cell 47:371–380PubMedCrossRefGoogle Scholar
  5. 5.
    Schinkel AH, Mayer U, Wagenaar E, Mol CA, van Deemter L, Smit JJ, van der Valk MA, Voordouw AC, Spits H, van Tellingen O, Zijlmans JM, Fibbe WE, Borst P (1997) Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins. Proc Natl Acad Sci USA 94:4028–4033PubMedCrossRefGoogle Scholar
  6. 6.
    Hughes CS, Vaden SL, Manaugh CA, Price GS, Hudson LC (1998) Modulation of doxorubicin concentration by cyclosporin A in brain and testicular barrier tissues expressing P-glycoprotein in rats. J Neuro-Onco 37:45–54CrossRefGoogle Scholar
  7. 7.
    Arboix M, Paz OG, Colombo T, D’Incalci M (1997) Multidrug resistance-reversing agents increase vinblastine distribution in normal tissues expressing the P-glycoprotein but do not enhance drug penetration in brain and testis. J Pharm Exp Ther 281:1226–1230Google Scholar
  8. 8.
    Uhr M, Steckler T, Yassouridis A, Holsboer F (2000) Penetration of amitriptyline, but not of fluoxetine, into brain is enhanced in mice with blood-brain barrier deficiency due to mdr1a P-glycoprotein gene disruption. Neuropsychopharmacology 22:380–387PubMedCrossRefGoogle Scholar
  9. 9.
    Choo EF, Leake B, Wandel C, Imamura H, Wood AJ, Wilkinson GR, Kim RB (2000) Pharmacological inhibition of P-glycoprotein transport enhances the distribution of HIV-1 protease inhibitors into brain and testes. Drug Metab Disp 28:655–660Google Scholar
  10. 10.
    Larriba S, Bassas L, Egozcue S, Gimenez J, Ramos MD, Briceno O, Estivill X, Casals T (2001) Adenosine triphosphate-binding cassette superfamily transporter gene expression in severe male infertility. Biol Reprod 65:394–400PubMedCrossRefGoogle Scholar
  11. 11.
    Ueda K, Okamura N, Hirai M, Tanigawara Y, Saeki T, Kioka N, Komano T, Hori R (1992) Human P-glycoprotein transports cortisol, aldosterone, and dexamethasone, but not progesterone. J Biol Chem 267:24248–24252PubMedGoogle Scholar
  12. 12.
    van Kalken CK, Broxterman HJ, Pinedo HM, Feller N, Dekker H, Lankelma J, Giaccone G (1993) Cortisol is transported by the multidrug resistance gene product P-glycoprotein. Br J Cancer 67:284–289PubMedGoogle Scholar
  13. 13.
    Barnes KM, Dickstein B, Cutler GB Jr, Fojo T, Bates SE (1996) Steroid treatment, accumulation, and antagonism of P-glycoprotein in multidrug-resistant cells. Biochemistry 35:4820–4827PubMedCrossRefGoogle Scholar
  14. 14.
    Axiotis CA, Guarch R, Merino MJ, Laporte N, Neumann RD (1991) P-glycoprotein expression is increased in human secretory and gestational endometrium. Lab Invest 65:577–581PubMedGoogle Scholar
  15. 15.
    Lee GY, Croop JM, Anderson E (1998) Multidrug resistance gene expression correlates with progesterone production in dehydroepiandrosterone-induced polycystic and equine chorionic gonadotropin-stimulated ovaries of prepubertal rats. Biol Reprod 58:330–337PubMedCrossRefGoogle Scholar
  16. 16.
    Parissenti AM, Gannon BR, Villeneuve DJ, Kirwan-rhude AF, Chadderton A, Gluck S (1999) Lack of modulation of MDR1 gene expression by dominant inhibition of cAMP-dependent protein kinase in doxorubicin-resistant MCF-7 breast cancer cells. Inter J Cancer 82:893–900CrossRefGoogle Scholar
  17. 17.
    Arai M, Yamauchi N, Fukuda H, Soh T, Hattori M-A (2006) Development of multidrug resistance type 1 P-glycoprotein function during in vitro maturation of porcine oocyte. Reprod Toxicol 21:34–41PubMedCrossRefGoogle Scholar
  18. 18.
    Fukuda H, Arai M, Yamauchi N, Soh T, Hattori M-A (2006) Progesterone regulates the expression and function of multidrug resistance type I in porcine granulosa cells. Reprod Toxicol 22:62–68PubMedCrossRefGoogle Scholar
  19. 19.
    Hattori M-A, Takesue K, Nishida N, Kato Y, Fujihara N (2000) Inhibitory action of retinoic acid in transformation of granulosa cells into luteal cells. J Mol Endocrinol 25:53–61PubMedCrossRefGoogle Scholar
  20. 20.
    Tokunaga K, Taniguchi H, Yoda K, Shimizu M, Sakiyama S (1986) Nucleotide sequence of a full-length cDNA for mouse cytoskeletal β-actin. Nuc Acid Res 14:2829CrossRefGoogle Scholar
  21. 21.
    He P-J, Fujimoto Y, Yamauchi N, Hattori M-A (2006) Real time monitoring of cAMP response element binding protein signaling in porcine granulosa cells modulated by ovarian factors. Mol Cell Biochem [in press]Google Scholar
  22. 22.
    Sato F, Kurokawa M, Yamauchi N, Hattori M-A (2006) Gene silencing of myostatin in chicken embryonic myoblasts by small interfering RNA. Am J Physiol 291:C538–C545CrossRefGoogle Scholar
  23. 23.
    Pickarz RL, Cohen D, Horwitz SB (1993) Progesterone regulates the murine multidrug resistance mdr1b gene. J Biol Chem 268:7613–7616Google Scholar
  24. 24.
    Kalabis GM, Kostaki A, Andrews MH, Petropoulos S, Gibb W, Matthews SG (2005) Multidrug resistance phosphoglycoprotein (ABCB1) in the mouse placenta: fetal protection. Biol Reprod 73:591–597PubMedCrossRefGoogle Scholar
  25. 25.
    Arceci RJ, Croop JM, Horwitz SB, Housman D (1988) The gene encoding multidrug resistance is induced and expressed at high levels during pregnancy in the secretory epithelium of the uterus. Proc Natl Acad Sci USA 85:4350–4354PubMedCrossRefGoogle Scholar
  26. 26.
    Yang CP, DePinho SG, Greenberger LM, Arceci RJ, Horwitz SB (1989) Progesterone interacts with P-glycoprotein in multidrug-resistant cells and in the endometrium of gravid uterus. J Biol Chem 264:782–788PubMedGoogle Scholar
  27. 27.
    Arceci RJ, Baas F, Raponi R, Horwitz SB, Housman D, Croop JM (1990) Multidrug resistance gene expression is controlled by steroid hormones in the secretory epithelium of the uterus. Mol Reprod Dev 25:101–109PubMedCrossRefGoogle Scholar
  28. 28.
    Geick A, Eichelbaum M, Burk O (2001) Nuclear receptor response elements mediate induction of intestinal MDR1 by rifampin. J Biol Chem 276:14581–14587PubMedCrossRefGoogle Scholar
  29. 29.
    Kim WK, Benet LZ (2004) P-glycoprotein (P-gp/MDR1)-mediated efflux of sex-steroid hormones and modulation of P-gp expression in vitro. Pharma Res 21:1284–1293CrossRefGoogle Scholar
  30. 30.
    Robinson LJ, Roberts WK, Ling TT, Lamming D, Sternberg SS, Roepe PD (1997) Human MDR1 protein overexpression delays the apoptotic cascade in Chinese hamster ovary fibroblasts. Biochemistry 36:11169–11178PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2006

Authors and Affiliations

  • Hiroaki Fukuda
    • 1
  • Pei Jian He
    • 1
  • Kazuko Yokota
    • 1
  • Tomoki Soh
    • 1
  • Nobuhiko Yamauchi
    • 1
  • Masa-aki Hattori
    • 1
  1. 1.Laboratory of Reproductive Physiology and Biotechnology, Department of Animal and Marine Bioresource Sciences, Faculty of AgricultureGraduate School Kyushu UniversityHigashi-kuJapan

Personalised recommendations